>_ QFI Terminal
Terminal › Stocks › TMO

Thermo Fisher Scientific Inc. (TMO) Stock

Healthcare · Medical - Diagnostics & Research · US
$717.71 -0.07%
Last updated Nov 12, 2026 09:10 UTC

TMO Key Statistics

Market Cap$265.92B
P/E (TTM)37.85
P/S (TTM)5.62
P/B (TTM)4.85
Revenue (TTM)$47.35B
EPS (TTM)$18.96
Dividend Yield0.28%
ROE (TTM)13.29%
Net Margin14.94%
Gross Margin41.44%
52W High$727.56
52W Low$435.27
Analyst ViewBuy
Price Target$694.27
Employees125,000
Volume1,816,267

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

CEO: Marc N. Casper. Company website

TMO — Frequently Asked Questions

What is the TMO stock price today?

Thermo Fisher Scientific Inc. (TMO) trades at $717.71, down 0.07% on the day, as of Nov 12, 2026 09:10 UTC.

What is Thermo Fisher Scientific Inc.'s market cap?

Thermo Fisher Scientific Inc. has a market capitalisation of $265.92B, calculated from the live TMO share price and shares outstanding.

What is the P/E ratio of TMO?

TMO trades at a trailing P/E of 37.85, from earnings per share of $18.96 over the last twelve months.

How much revenue does Thermo Fisher Scientific Inc. make?

Thermo Fisher Scientific Inc. generated revenue of $47.35B over the trailing twelve months, which puts the stock at 5.62 times sales.

Does TMO pay a dividend?

Yes. Thermo Fisher Scientific Inc. pays a dividend yielding 0.28% on the current share price.

What is the 52-week range for TMO?

TMO has traded between $435.27 and $727.56 over the past 52 weeks, and the last price is 1.4% below that high.

Is Thermo Fisher Scientific Inc. profitable?

Yes. Thermo Fisher Scientific Inc. keeps 14.94% of revenue as net income over the trailing twelve months.

What is the analyst price target for TMO?

Wall Street analysts rate TMO Buy, with an average price target of $694.27, 3.3% below the current price.

What sector is Thermo Fisher Scientific Inc. in?

Thermo Fisher Scientific Inc. is classified under the Healthcare sector and the Medical - Diagnostics & Research industry, and is domiciled in US.

Who is the CEO of Thermo Fisher Scientific Inc.?

Marc N. Casper is the chief executive of Thermo Fisher Scientific Inc., which employs 125,000 people.

Where can I track TMO in real time?

QFI Terminal shows TMO with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See TMO live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open TMO in Terminal See plans

Medical - Diagnostics & Research stocks

DHR Danaher Corporation IQV IQVIA Holdings Inc. LH Labcorp Holdings Inc. DGX Quest Diagnostics Incorporated ICLR ICON Public Limited Company A Agilent Technologies, Inc. WAT Waters Corporation IDXX IDEXX Laboratories, Inc. ILMN Illumina, Inc. MTD Mettler-Toledo International Inc. CRL Charles River Laboratories International, Inc. EXAS Exact Sciences Corporation RVTY Revvity, Inc. NTRA Natera, Inc. MEDP Medpace Holdings, Inc. QGEN Qiagen N.V. GH Guardant Health, Inc. SHC Sotera Health Company MYGN Myriad Genetics, Inc. NEO NeoGenomics, Inc. NOTV Inotiv, Inc. OPK OPKO Health, Inc. ATLN Atlantic International Corp. CDNA CareDx, Inc

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company HCA HCA Healthcare, Inc. MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc.

ETFs holding TMO

XLV State Street Health Care Select Sector SPDR ETF 3.91% PCLN Pictet Cleaner Planet ETF 1.42% VTV Vanguard Morningstar Value ETF 0.95% SCHG Schwab U.S. Large-Cap Growth ETF 0.73% IWD iShares Russell 1000 Value ETF 0.67% FNDX Schwab Fundamental U.S. Large Company ETF 0.42% SPY State Street SPDR S&P 500 ETF 0.41% IVV iShares Core S&P 500 ETF 0.39% VOO Vanguard S&P 500 ETF 0.38% SCHX Schwab U.S. Large-Cap ETF 0.37% IWB iShares Russell 1000 ETF 0.37% FB ProShares S&P 500 Dynamic Buffer ETF 0.36% SCHB Schwab U.S. Broad Market ETF 0.35% VTI Vanguard Morningstar Total Stock Market ETF 0.34% ACWI iShares MSCI ACWI ETF 0.25% RSP Invesco S&P 500 Equal Weight ETF 0.22% UPRO ProShares - UltraPro S&P500 0.22% VT Vanguard Total World Stock ETF 0.21% DGRO iShares Core Dividend Growth ETF 0.17% INFO Harbor PanAgora Dynamic Large Cap Core ETF 0.13% SPXL Direxion Daily S&P 500 Bull 3X Shares 0.09%

Largest institutional holders of TMO

BlackRock, Inc. BLK 30,919,632 shares
VANGUARD CAPITAL MANAGEMENT LLC 24,276,316 shares
FMR LLC 22,173,792 shares
STATE STREET CORP STT 16,825,879 shares
MORGAN STANLEY MS 10,763,066 shares
JPMORGAN CHASE & CO JPM 8,503,527 shares
GEODE CAPITAL MANAGEMENT, LLC 8,462,804 shares
FRANKLIN TEMPLETON INC 7,271,514 shares
FRANKLIN RESOURCES INC BEN 7,271,514 shares
VANGUARD PORTFOLIO MANAGEMENT LLC 6,226,169 shares

TMO insiders on other boards

BEN Franklin Resources, Inc. Johnson Jennifer M WST West Pharmaceutical Services, Inc. Lagarde Michel DD DuPont de Nemours, Inc. Chandy Ruby R FLS Flowserve Corporation Chandy Ruby R HON Honeywell International Inc. Williamson Stephen CB Chubb Limited Chai Nelson AMGN Amgen Inc. Jacks Tyler INTC Intel Corp. Weisler Dion J CL Colgate-Palmolive Company Harris C Martin VRTX Vertex Pharmaceuticals Incorporated Lagarde Michel HPQ HP Inc. Pettiti Gianluca HSIC Henry Schein, Inc. Lowery Frederick M.